论文部分内容阅读
广东省药物研究所附属医院担负着国家的药物开发、研究与临床实践相结合的重任,具有一流的技术力量,配置了一大批高、精、尖的医疗器械及检测仪器,同时还引进国内外领先的新技术、新项目,自1988年首批成功研发了治疗心脑血管疾病、冠心病新特药物荣获专利以来,又相继开发了治疗乙肝、肿瘤等特效药物。特别倍受关注的泌尿科治疗中心,在唐锦超教授的带领下,更是久负盛名。唐教授曾代表本院数次出席亚太20多个国家、医药学术交流会,发表数百
Guangdong Provincial Institute of Materia Medica Affiliated Hospital is responsible for the national drug development, research and clinical practice of combining the important task, with first-class technology, equipped with a large number of high, refined, sharp medical equipment and testing instruments, but also the introduction of domestic and foreign Leading new technologies and projects, since 1988, the first batch of successful research and development of cardiovascular and cerebrovascular diseases, new patents for coronary heart disease won the patent since, have also developed special drugs for the treatment of hepatitis B, cancer and other effects. Particularly concerned about the urological treatment center, under the leadership of Professor Tang Jinchao is even prestigious. Professor Tang has represented our hospital several times in more than 20 countries and medical and academic exchanges in Asia Pacific and published hundreds